PPB Approval

DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML

Registration Code

HK-68305

Sale Requirement

Prescription only Medicines

Registration Date

July 16, 2024

Company NameSciclone Pharmaceuticals International Ltd.

Company Information

Company Details

Company NameSciclone Pharmaceuticals International Ltd.

Company Address

UNIT 3, 14/F, CHEUNG FUNG INDUSTRIAL BUILDING, 23-39, PAK TIN PAR STREET, TSUEN WAN, NEW TERRITORIES

Active Ingredients

Ingredient Name

naxitamab

Drug Monographs

English NameNaxitamab

Chinese Name

那西妥单抗

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML - PPB 批准文号 | MedPath